Resources

Emmanuel Walckenaer, CEO of Yseop, dives into how medical writers and pharma companies can get started in AI 101: Guide for Medical Writers.

Gartner’s analysis indicates a significant shift in generative AI, moving from rapid growth to stabilization and incremental improvements. At Yseop, we embrace this evolution, continuously enhancing our platform to deliver reliable and efficient AI solutions. Learn how we capitalize on the current phase to drive the future of AI-driven content generation.

Cognizant’s AI and industry expertise, combined with Yseop’s generative AI platform, aims to improve the productivity of scientific writers across the life sciences value chain

In the ever-evolving pharmaceutical landscape, the integration of artificial intelligence (AI) in clinical trials is a game-changer, enhancing efficiency and effectiveness. By exploring the advantages of AI in late-stage drug development, we reveal how AI optimizes clinical trials, streamlines data collection, and improves patient recruitment and retention. Dive in to discover how AI can transform your drug development process and position your organization at the forefront of innovation.

Listen to the ninth episode of AI Uncovered with Rohit Sood

Discover how Yseop, a French start-up, teams up with AWS to revolutionize clinical trials using AI for faster drug development.

Already a leading provider of Generative AI for life sciences, Yseop leverages AWS for greater scalability and the acceleration of new drug introductions

Discover the transformative potential of Generative AI in pharmaceuticals. Dive into five essential steps for implementation and investment, from leveraging competitive advantages to ensuring compliance with industry standards. Unveil the future of Pharma innovation with Generative AI.

Finalists at the 2024 Citeline Awards for the Best Use of Artificial Intelligence in Clinical Trials